Kyntra Bio's total assets for Q4 2025 were $119.59M, a decrease of -12.71% from the previous quarter. KYNB total liabilities were $115.12M for the fiscal quarter, a -3.69% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.